Baidu
map

2019 SFE共识声明:老年甲状腺功能不全的管理

2020-05-04 国外内分泌相关专家小组(统称) Ann Endocrinol (Paris) . 2020 May 4.

法国内分泌学会(SFE)发布的老年甲状腺功能不全的管理共识主要内容涉及甲状腺功能不全的筛查、治疗等内容。

中文标题:

2019 SFE共识声明:老年甲状腺功能不全的管理

英文标题:

Management of Thyroid Dysfunctions in the Elderly. French Endocrine Society Consensus Statement 2019

发布日期:

2020-05-04

简要介绍:

法国内分泌学会(SFE)发布的老年甲状腺功能不全的管理共识主要内容涉及甲状腺功能不全的筛查、治疗等内容。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2019 SFE共识声明:老年甲状腺功能不全的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=43dde1c0019086de, title=2019 SFE共识声明:老年甲状腺功能不全的管理, enTitle=Management of Thyroid Dysfunctions in the Elderly. French Endocrine Society Consensus Statement 2019, guiderFrom=Ann Endocrinol (Paris) . 2020 May 4., authorId=0, author=, summary=法国内分泌学会(SFE)发布的老年甲状腺功能不全的管理共识主要内容涉及甲状腺功能不全的筛查、治疗等内容。, cover=https://img.medsci.cn/2020523/1590245505345_2020535.jpg, journalId=0, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon May 04 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>法国内分泌学会(SFE)发布的老年甲状腺功能不全的管理共识主要内容涉及甲状腺功能不全的筛查、治疗等内容。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=103609, tagName=甲状腺功能不全)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3311, guiderKeyword=甲状腺功能, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2538, appHits=210, showAppHits=124, pcHits=413, showPcHits=2429, likes=0, shares=12, comments=8, approvalStatus=1, publishedTime=Sat May 23 23:24:16 CST 2020, publishedTimeString=2020-05-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 23 22:51:48 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:37:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2019 SFE共识声明:老年甲状腺功能不全的管理.pdf)])
2019 SFE共识声明:老年甲状腺功能不全的管理.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1052097, encodeId=ad4d105209ebf, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb15502383, createdName=良耳, createdTime=Thu Sep 16 21:35:45 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970338, encodeId=30799e03382f, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/f4066a3466174118bbcf981dffefd6cc/323f92182d7b49f58ee342ede68363fa.jpg, createdBy=2b765496135, createdName=ms3000001777893761, createdTime=Wed Jun 02 13:59:05 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945970, encodeId=da359459e0e7, content=l, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d42954506, createdName=128fc9cam76暂无昵称, createdTime=Sat Mar 06 16:41:59 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944777, encodeId=3f07944e7754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:45:18 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895454, encodeId=d7c189545405, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Thu Oct 29 17:04:02 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-09-16 良耳

    怎么导出

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1052097, encodeId=ad4d105209ebf, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb15502383, createdName=良耳, createdTime=Thu Sep 16 21:35:45 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970338, encodeId=30799e03382f, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/f4066a3466174118bbcf981dffefd6cc/323f92182d7b49f58ee342ede68363fa.jpg, createdBy=2b765496135, createdName=ms3000001777893761, createdTime=Wed Jun 02 13:59:05 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945970, encodeId=da359459e0e7, content=l, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d42954506, createdName=128fc9cam76暂无昵称, createdTime=Sat Mar 06 16:41:59 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944777, encodeId=3f07944e7754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:45:18 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895454, encodeId=d7c189545405, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Thu Oct 29 17:04:02 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-06-02 ms3000001777893761

    怎么导出

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1052097, encodeId=ad4d105209ebf, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb15502383, createdName=良耳, createdTime=Thu Sep 16 21:35:45 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970338, encodeId=30799e03382f, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/f4066a3466174118bbcf981dffefd6cc/323f92182d7b49f58ee342ede68363fa.jpg, createdBy=2b765496135, createdName=ms3000001777893761, createdTime=Wed Jun 02 13:59:05 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945970, encodeId=da359459e0e7, content=l, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d42954506, createdName=128fc9cam76暂无昵称, createdTime=Sat Mar 06 16:41:59 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944777, encodeId=3f07944e7754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:45:18 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895454, encodeId=d7c189545405, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Thu Oct 29 17:04:02 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1052097, encodeId=ad4d105209ebf, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb15502383, createdName=良耳, createdTime=Thu Sep 16 21:35:45 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970338, encodeId=30799e03382f, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/f4066a3466174118bbcf981dffefd6cc/323f92182d7b49f58ee342ede68363fa.jpg, createdBy=2b765496135, createdName=ms3000001777893761, createdTime=Wed Jun 02 13:59:05 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945970, encodeId=da359459e0e7, content=l, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d42954506, createdName=128fc9cam76暂无昵称, createdTime=Sat Mar 06 16:41:59 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944777, encodeId=3f07944e7754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:45:18 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895454, encodeId=d7c189545405, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Thu Oct 29 17:04:02 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2021-03-02 ms5000002046462755

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1052097, encodeId=ad4d105209ebf, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb15502383, createdName=良耳, createdTime=Thu Sep 16 21:35:45 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970338, encodeId=30799e03382f, content=怎么导出, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/f4066a3466174118bbcf981dffefd6cc/323f92182d7b49f58ee342ede68363fa.jpg, createdBy=2b765496135, createdName=ms3000001777893761, createdTime=Wed Jun 02 13:59:05 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945970, encodeId=da359459e0e7, content=l, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8d42954506, createdName=128fc9cam76暂无昵称, createdTime=Sat Mar 06 16:41:59 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944777, encodeId=3f07944e7754, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:45:18 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895454, encodeId=d7c189545405, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Thu Oct 29 17:04:02 CST 2020, time=2020-10-29, status=1, ipAttribution=)]
    2020-10-29 kenblue

    学习学习

    0

拓展阅读

2015 ESPE共识指南:先天性甲状腺功能减退症筛查、诊断和管理

欧洲儿科内分泌学会(ESPE,European Society for Paediatric Endocrinology) · 2015-03-16

2021 ETA指南:碘基造影剂致甲状腺功能异常的管理

欧洲甲状腺协会(ETA,European Thyroid Association) · 2021-07-15

Baidu
map
Baidu
map
Baidu
map